5-hydroxymethyldeoxycytidine monophosphate has been researched along with Hypoxia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, L; Su, H; Sun, M; Xu, Z; Zhang, P; Zhang, Y; Zhou, X | 1 |
1 other study(ies) available for 5-hydroxymethyldeoxycytidine monophosphate and Hypoxia
| Article | Year |
|---|---|
Tet3 enhances IL-6 expression through up-regulation of 5-hmC in IL-6 promoter in chronic hypoxia induced atherosclerosis in offspring rats.
Topics: Animals; Atherosclerosis; Cell Movement; Cell Survival; Deoxycytidine; Dioxygenases; Epigenesis, Genetic; Female; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-6; Male; Mixed Function Oxygenases; Pregnancy; Pregnancy Complications; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; RNA, Messenger; Transcriptional Activation; Up-Regulation | 2019 |